BCAX
Bicara Therapeutics Inc
NASDAQ · Biotechnology
$15.36
+0.26 (+1.72%)
Open$15.53
Previous Close$15.10
Day High$16.00
Day Low$14.90
52W High$19.71
52W Low$7.80
Volume—
Avg Volume365.5K
Market Cap841.45M
P/E Ratio—
EPS$-5.03
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-5.6% upside
Current
$15.36
$15.36
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 181.36M | 184.14M | 159.71M |
| Net Income | -39,755,825 | -41,476,631 | -32,201,263 |
| Profit Margin | -21.9% | -22.5% | -20.2% |
| EBITDA | -52,674,751 | -54,395,580 | -46,526,832 |
| Free Cash Flow | -41,149,249 | -44,589,211 | -37,987,097 |
| Rev Growth | +5.9% | -5.2% | -5.4% |
| Debt/Equity | 0.58 | 0.56 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |